Magic mushroom therapy tested for End-of-Life distress
NCT ID NCT04950608
First seen Oct 31, 2025 · Last updated Jun 14, 2026 · Updated 32 times
Summary
This pilot study tested whether psilocybin (the active ingredient in magic mushrooms) combined with talk therapy could help reduce feelings of demoralization in people receiving hospice care. Fifteen terminally ill adults participated. The main goal was to see if the approach was practical and acceptable, not to prove it works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSILOCYBIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Care Dimensions
Danvers, Massachusetts, 01923, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.